Introduction The management of intraductal papillomas of the breast has been controversial;
some advocate surgical excision of all lesions despite benign pathologic features, whereas …

In many centers internationally, current standard of care is to excise all papillomas of the
breast, despite recently reported low rates of upgrade to malignancy on final excision. The …

Objectives This study aims to evaluate the feasibility of Breast Lesion Excision System
(BLES) in the treatment of intraductal papillomas. Material and methods All patients with a …

PURPOSE The clinical management of high-risk lesions using image-guided biopsy is
challenging. This study aimed to evaluate the rates at which such lesions were upgraded to …

Background Breast intraductal papilloma is a heterogeneous group. The aim of the study is
to investigate the intraductal breast papilloma and its coexisting lesions retrospectively in …

The distinction between benign and malignant papilloma of the breast through
percutaneous needle biopsy can be difficult because of limited samples; the …

Prediction of subsequent risks of breast carcinoma (BC) development in intraductal
papilloma (IDP) has remained controversial with the exception of atypical papilloma (AP) …

The differentiation of intraductal papilloma (IDP) in the breast from ductal carcinoma in situ
(DCIS) is sometimes difficult. Fifty papillary lesions (25 DCIS and 25 IDP) were …

Purpose Intraductal papilloma (IDP) is a benign breast disease with malignant potential, for
which complete surgical excision is usually recommended. The aim of the present study was …

Management of benign breast lesions diagnosed by core needle biopsy (CNB) remains a
controversial topic. Specifically, there is no consensus on the management of intraductal …